SCHEMBL17526005

SCHEMBL17526005

C=C/C=C\C=C(/C)CN(C(C)=O)c1cc(N(Cc2ccccc2)C(C)=O)ncn1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.41
FGFR4 P22455 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
POLB P06746 1/20 0.36
TSHR P16473 1/20 0.34
LCK P06239 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19650787 0.82 TSPO (0.56) TSPOKMT2AMEN1L3MBTL1POLB
SCHEMBL24258421 0.76 TSPO (0.43) TSPOKMT2AMEN1L3MBTL1POLB
SCHEMBL19655675 0.70 TSPO (0.43) TSPOKMT2AMEN1L3MBTL1POLB
SCHEMBL7776521 0.66 POLB (0.71) KMT2AMEN1L3MBTL1POLBTSHR
SCHEMBL19187746 0.65 CES2 (0.38) KMT2AMEN1TSHRALDH1A1
SCHEMBL18536172 0.64 CES2 (0.39) KMT2AMEN1L3MBTL1TSHRKDM4E
SCHEMBL27741606 0.62 TSPO (0.55) TSPOKMT2AMEN1L3MBTL1POLB
SCHEMBL23121606 0.62 TSPO (0.50) TSPOKMT2AMEN1L3MBTL1POLB
SCHEMBL5694553 0.62 TSPO (0.72) TSPOTSHRLTB4R2CRHBPCRHR2
SCHEMBL23121611 0.62 TSPO (0.50) TSPOKMT2AMEN1L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016020288-A1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION A/S (DK) 2016-02-11 WO disclosed